madafakaa

I'm not confident but it worths to watch.

Long
NASDAQ:NVIV   InVivo Therapeutics Holdings Corp
Direct offering in april was at price $1.75 per share, it has to have a tendency to reach that level first.

Volume is low, let's just keep it under the radar.

PT1 - 1.79
PT2 - 2.24
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.